New York Presbyterian Hospital in New York, NY

About This Facility

Directory information from SAMHSA N-SUMHSS 2025. This listing is not an endorsement or independent verification. Confirm current services, eligibility, and availability directly with the facility.

Services Listed in the Directory

• Adults

  Facility accepts adults (26-64) for treatment.

• Sign language services for the deaf and hard of hearing

  Service provided for persons who are deaf and hard of hearing.

• Buprenorphine used in Treatment

  Buprenorphine is used in medication-assisted treatment (MAT) to help people reduce or quit their use of heroin or other opiates.

• Buprenorphine maintenance

• Buprenorphine with naloxone

  A prescription medication that combines buprenorphine (which helps relieve symptoms of opiate withdrawal) and naloxone (reverse the effects of narcotics) used to treat opioid addiction.

• Cash or self-payment

  Payment for treatment is made by the person directly, through cash or other means, rather than using health insurance.

• Clients with co-occurring pain and substance use disorders

• Comprehensive substance use assessment

• Drug and alcohol oral fluid testing

• Drug or alcohol urine screening

  Analyzes your urine for the presence of certain illegal drugs and prescription medications.

• Drug Enforcement Agency (DEA)

• Female

  Female

• Federally Qualified Health Center

  An entity may qualify as a FQHC if it meets one of these requirements (CMS, 2017): Is receiving a grant under Section 330 of the Public Health Service (PHS) Act or is receiving funding from such a grant and meets other requirements; Is not receiving a grant under Section 330 of the PHS Act, but is determined by the Secretary of the Department of Health and Human Services (HHS) to meet the requirements for receiving such a grant (i.e., qualifies as a FQHC look-alike) based on the recommendation of the Health Resources and Services Administration (HRSA); Was treated by the Secretary of the Department of HHS for purposes of Medicare Part B as a comprehensive Federally-funded health center as of January 1, 1990; Is operating as an outpatient health program or facility of a tribe or tribal organization under the Indian Self-Determination Act or as an urban Indian organization receiving funds under Title V of the Indian Health Care Improvement Act as of October 1, 1991.

• General Hospital (including VA hospital)

  A hospital in which patients with many different types of ailments are given care.

• Testing for Hepatitis B (HBV)

  Involves blood test that measure HBV (Hepatitis B virus) antigens and antibodies.

• Testing for Hepatitis C (HCV)

  Test for Hepatitis C, which is usually done and recommended for persons currently injecting drugs, ever injected drugs, were prior recipients of transfusions or organ transplants, or have certain medical conditions, including persons: 1. who received clotting factor concentrates produced before 1987 2. who were ever on long-term hemodialysis 3. with persistently abnormal alanine aminotransferase levels (ALT) 4. who have HIV infection

• The Joint Commission

  An independent, not-for-profit group in the United States that administers voluntary accreditation programs for hospitals and other healthcare organizations.

• Male

  Male

• Medicare

  The federal health insurance program for people age 65 and older and people with disabilities.

• Medicaid

  A joint federal and state program that helps with medical costs for some people with low incomes and limited resources. Medicaid programs vary from state to state.

• Methadone

  Methadone is a long-acting medication that reduces cravings and withdrawal symptoms. It can block the euphoric effects of short-acting opioids, such as heroin. Methadone is usually taken daily as a drinkable liquid. It can be dispensed only at licensed, federally-regulated opioid treatment programs, so having reliable daily transportation to a clinic is important while taking methadone.

• Complete medical history/physical exam

• Clients with co-occurring mental and substance use disorders

  Facility has a program or group specifically tailored for persons with co-occurring mental and substance abuse disorders.

• Methadone maintenance

  Comprehensive treatment program that involves the long-term prescribing of methadone as an alternative to the opioid on which the client was dependent.

• Medication for mental disorders

• Metabolic syndrome monitoring

• Methadone used in Treatment

• Does not treat alcohol use disorder

• Naloxone and overdose education

• Outpatient methadone/buprenorphine or naltrexone treatment

• Outpatient

  Describes patients who receive treatment services without an overnight stay at a treatment facility or hospital.

• Federally-certified Opioid Treatment Program

  The process by which the SAMHSA Center for Substance Abuse Treatment, Division of Pharmacologic Therapies determines that an OTP is qualified to provide opioid treatment under 42 CFR Part 8. For additional information on the OTP certification process, see http://www.samhsa.gov/medication-assisted-treatment/opioid-treatment-programs/.

• Opioid use disorder clients only

• Private non-profit organization

  A charitable organization that does not qualify as a public charity.

• Substance use treatment

  Refers to a range of services, including problem identification and diagnosis, brief interventions, assessment of substance use and related problems, treatment planning, counseling, medical services, psychiatric services, psychological services, social services, and follow-up for persons with alcohol or other drug problems (Institute of Medicine, 1990).

• Smoking not permitted

  Smoking is not allowed.

• SAMHSA certification for opioid treatment program (OTP)

• State substance use treatment agency

  Government organization responsible for planning, organizing, delivering, and monitoring substance use disorder services in their respective state.

• Screening for substance use

  Test to determine whether a person is experiencing symptoms of substance use and needs treatment.

• State department of health

• Screening for tobacco use

  Determines a client's use of tobacco products, such as cigarettes, cigars, pipe tobacco, or smokeless tobacco. It is generally recommended that providers screen for tobacco use on a regular basis by asking clients, as they are seen, about their current and past use of tobacco products and their exposure to secondhand smoke or tobacco.

• Treatment for co-occurring substance use plus either serious mental illness (SMI) in adults and/or serious emotional disturbance (SED) in children

  Refers to treatment services intended to help their clients’ ability to function as a result of substance use and/or mental disorders. By definition, serious mental illness is someone over 18 having (within the past year) a diagnosable mental, behavior, or emotional disorder that causes serious functional impairment that substantially interferes with or limits one or more major life activities. For people under the age of 18, the term ‟Serious Emotional Disturbance” refers to a diagnosable mental, behavioral, or emotional disorder in the past year, which resulted in functional impairment that substantially interferes with or limits the child’s role or functioning in family, school, or community activities.

• TB screening

  Skin tests that are used to screen people who are at high risk for TB exposure such as people with diseases or conditions that weaken their immune system.

• Telemedicine/telehealth therapy

  The ability for healthcare providers, working remotely and using telecommunications technology, to communicate with patients, diagnose conditions, provide treatment, and discuss healthcare issues with other providers to ensure quality healthcare services are provided.

• Prescribes buprenorphine

• Vaping not permitted

• Young Adults

  Facility accepts young adults (18-25) for treatment.

Contact and Location

503 East 70th Street, 1st Floor, New York, NY, 10021

Phone: 212-746-9229